Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
21 USD | +11,29% | +5,69% | -1,96% |
16/04 | ANAPTYSBIO, INC. : Leerink Partners nog altijd een koopadvies | ZM |
11/04 | ANAPTYSBIO, INC. : Wells Fargo Securities nog altijd een koopadvies | ZM |
Vakgebied
Aantal werknemers: 117
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
GSK - Royalty
100,0
%
| 5 | 51,4 % | 17 | 100,0 % | +224,51% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States and Australia
100,0
%
| 10 | 100,0 % | 17 | 100,0 % | +66,78% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel Faga
CEO | Chief Executive Officer | 44 | 26-11-21 |
Dennis Mulroy
DFI | Director of Finance/CFO | 69 | 15-07-20 |
Paul Lizzul
CTO | Chief Tech/Sci/R&D Officer | 49 | 31-07-20 |
Nick Montemarano
IRC | Investor Relations Contact | - | - |
Priya Raina
PRN | Corporate Officer/Principal | - | 01-07-22 |
Ben Stone
PRN | Corporate Officer/Principal | - | 01-01-22 |
Martin Dahl
PRN | Corporate Officer/Principal | - | 01-01-18 |
Beth Mueller
HRO | Human Resources Officer | - | 01-10-19 |
David McKeon
AUD | Comptroller/Controller/Auditor | 52 | 01-04-17 |
Lewis Gryziewicz
LAW | General Counsel | - | 01-01-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Hollings Renton
BRD | Director/Board Member | 77 | 30-06-15 |
Dennis Fenton
BRD | Director/Board Member | 72 | 05-03-18 |
Magda Marquet
BRD | Director/Board Member | 65 | 18-01-21 |
Oleg Nodelman
BRD | Director/Board Member | 47 | 08-04-21 |
John Schmid
BRD | Director/Board Member | 60 | 30-06-15 |
John Orwin
CHM | Chairman | 59 | 15-09-23 |
J. Ware
BRD | Director/Board Member | 71 | 24-08-17 |
Daniel Faga
CEO | Chief Executive Officer | 44 | 26-11-21 |
Rita Jain
BRD | Director/Board Member | 62 | 06-04-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 27 318 644 | 27 211 653 ( 99,61 %) | 0 | 99,61 % |
Bedrijfsgegevens
AnaptysBio, Inc.
10770 Wateridge Circle Suite 210
92121-5801, San Diego
+858 362 6295
http://www.anaptysbio.comSector
Verkoop per activiteit
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,96% | 574 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers ANAB
- Onderneming AnaptysBio, Inc.